socalTECH

OCTOBER 12, 2012

Thousand Oaks-based energy crop developer Ceres , which develops agriculutural biotechnology for the renewable fuels market, said Tuesday that Richard Flavell, PhD., Flavell remains on the company's board. The company said the new position makes Flavell a consultant to the company.

Thousand Oaks 138

Thousand Oaks Marketing Product Develop 138

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Financial terms of the deal were not disclosed.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

MAY 5, 2014

Thousand Oaks-based agricultural biotechnology developer Ceres , which is developing biotech-driven sorghum seeds for use in reneable fuel and electricity production, said it has expanded its product develoment activities in Meixco. The company said the move of production to Mexico should help it deliver products faster.

Product 138

Product Thousand Oaks Research Sites 138

socalTECH

SEPTEMBER 3, 2015

Thousand Oaks-based agricultural biotechnology developer Ceres said today that it is expanding its commercial evaluation of its seeds in Puerto Rico. Ceres uses advanced plant breeding and biotechnology to create seed hybrids with better yields and ability to handle different growing conditions. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Product Help Marketing 100

socalTECH

MAY 31, 2012

BlueView develops instrumentation used for underwater vision, monitoring, survey, detection and navigation. The company was based in Seattle. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Technology Acquisition Software 140

socalTECH

AUGUST 23, 2012

Thousand Oaks-based Ceres , the developer of seeds for the energy and biofuels market, announced yesterday that it has added former BP Chief Scientist and Undersecretary of Energy for Science, Steven E. The company said that its board now includes 12 members. Koonin, to its board of directors. READ MORE>>.

Thousand Oaks 133

Thousand Oaks CalTech Marketing Develop 133

socalTECH

MAY 29, 2013

Thousand Oaks-based biotech Amgen announced today that it has linked with Astellas Pharma , in a deal to reach the Japanese market with new medicines. The companies will also create a Tokyo-based joint venture, Amgen Astellas BioPharma KK. Financial details of the strategic alliance were not disclosed.

Thousand Oaks 138

Thousand Oaks Marketing Develop Development 138

socalTECH

FEBRUARY 28, 2012

Thousand Oaks-based Ceres , the developer of seed stock for energy crops, said today that it has closed its IPO, selling a total of 5,750,000 shares of its common stock at $13.00 The firm said its underwriters exercise their full option to purchase an additional 750,000 shares of common stock from the company as part of the IPO.

Thousand Oaks 140

Thousand Oaks Southern California Marketing Capital 140

socalTECH

APRIL 2, 2012

Thousand Oaks-based storage systems developer Nexsan has officially pulled its IPO plans, saying in a regulatory filing today with the SEC that it has decided to withdraw its IPO registration. Nexsan, which had filed for an IPO in April of 2008, cited "unfavorable market conditions" for the withdrawal. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Marketing Technology Develop 140

socalTECH

FEBRUARY 23, 2012

Thousand Oaks-based Ceres , the biotechnology firm developing specialized seed stocks for the biofuels industry, rose in its IPO on Wednesday, closing at $14.80 Ceres develops specialized seeds specifically for growing feedstock for biofuels and biochemicals. The firm priced its IPO on Tuesday evening at $13.00

Thousand Oaks 145

Thousand Oaks Southern California Pricing Activity 145

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150

Pricing Thousand Oaks Startup Design 150

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. per share, raising up to $132.25M for the company. and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

APRIL 12, 2010

Thousand Oaks-based Nexsan , a developer of data storage systems, has delayed its IPO, according to its underwriter, Thomas Weisel Partners. According to Thomas Weisel Partners Friday, the IPO is being delayed by market conditions. a share on the NASDAQ Global market in early March, hoping to raise around $55M.

Thousand Oaks 145

Thousand Oaks Marketing Capital Develop 145

socalTECH

MAY 23, 2011

Thousand Oaks-based Ceres , the developer of seeds aimed at producing renewable, biomass feedstocks for the biofuels industry, has filed for an IPO. According to a filing this morning by the firm, the company is aiming to raise up to $100M in an IPO on the NASDAQ Global Market as CERE. and Barclays Capital.

Thousand Oaks 140

Thousand Oaks .Net Capital Marketing 140

socalTECH

JANUARY 27, 2011

In a sign that Thousand Oaks-based Nexsan might be ramping up its IPO efforts again, after a delay last year, the firm filed an updated S-1 this week. on the NASDAQ Global Market as NXSN. The firm now lists its underwriters as Piper Jaffray, William Blair & Company, and Needham & Company, LLC.

Thousand Oaks 147

Thousand Oaks .Net Report Marketing 147

socalTECH

SEPTEMBER 8, 2010

Thousand Oaks-based Xirrus , the developer of wireless switching hardware and enterprise Wi-Fi equipment, is bragging this morning that it ranks second to Cisco Systems, in enterprise wireless hardware revenue. No financial details of shipments were released by the company. READ MORE>>.

Thousand Oaks 113

Thousand Oaks Report Marketing Develop 113

socalTECH

JUNE 17, 2010

In the latest Southern California firm to target the public markets, Inphi Corp. , a developer of high speed, analog semiconductors, has filed for an IPO, saying late Wednesday evening in a filing with the SEC it is looking to raise up to $115M in an IPO on the NYSE. In its S-1, the firm said it had net income of $7.3M

Westlake Village 133

Westlake Village Thousand Oaks Southern California .Net 133

Xconomy

SEPTEMBER 30, 2016

Who will be first to market with a new type of cancer treatment known as CAR-T? Who will break free of the pack of companies developing drugs meant to prevent migraines? —Sarepta inked a research pact with Catabasis Pharmaceuticals (NASDAQ: CATB ) to develop a combination therapy for Duchenne.

Avalon 40

Avalon Thousand Oaks Study Startup 40

socalTECH

APRIL 29, 2014

We spoke with Mike Outmesguine , CEO and Alan DeRossett , CTO of the company, and how their roots in do-it-yourself, "Maker" projects is key to their entry into the prize competition. The company actually was working on a different project which had dried up at that point, and it was just natural to step into this at that point.

Startup 262

Startup Competition Software Review UCLA 262

Xconomy

AUGUST 26, 2016

The company shares rights to its lead drug enzalutamide (Xtandi) with Astellas Pharma and its second drug, talazoparib, a type of cancer treatment called a PARP inhibitor, awaits crucial Phase 3 data next year. The company gave no reason for the rejection. Whether Medivation will be worth the price remains to be seen. Morgan party.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Xconomy

JUNE 10, 2016

The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. —More developments arrived this week in the Sarepta Therapeutics (NASDAQ: SRPT ) saga. The full data set has yet to be released.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Xconomy

JULY 22, 2016

The top news in biotech this week centers around one big job opening: the head seat at Biogen, now that George Scangos has announced plans to leave the company. Who takes the gig, and the strategic direction he or she chooses for Biogen will have implications not just for the company and its employees, but the sector overall.

Startup 40

Startup San Diego News Thousand Oaks 40

Xconomy

AUGUST 5, 2016

Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. Instead, Holmes promoted a new system, MiniLab , in development. Verily is the biotech group at Google’s parent company Alphabet (NASDAQ: [[ticker:GOOG:]]).

News 40

News Thousand Oaks Pricing Report 40